Cite Filings / COGT / 0002012383-26-000802

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Cogent Biosciences, Inc. Filed 2026-01-21 Acc 0002012383-26-000802

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-01-30 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-01-22 4 Director sold 3,500,000 shares at $36.40 ($127,400,000)
2026-01-22 144 Sale of Securities
2026-01-22 SCHEDULE 13D/A Beneficial Ownership Report
2026-01-21 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-01-21 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…